K202267 is an FDA 510(k) clearance for the Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).
Submitted by Isoray Medical, Inc. (Richland, US). The FDA issued a Cleared decision on December 31, 2020, 142 days after receiving the submission on August 11, 2020.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.